| |
| |
- API
Division of AARTI INDUSTRIES LTD.,
Flagship Company of USD 189 Million “AARTI
GROUP”, since 1976, exporting
to more than 65 countries, including Developed
and developing Markets.
- API
Division manufacturing APIs, in niche segments
Viz: Anti – Hypertensive, Anti –Asthamatic,
Anti-Cancer, Anti- Inflammatory / Anti- Allergic,
Anti- Diabetic, Anti- Depressants, Anti- Thalassaemic.(
Pl. refer to Product List ).
- Manufacturing
Units at Dombivali & Tarapur , in Maharashtra
State of India, will be WHO GMP Approved facilities
by End Dec.2003.
- Brand
New facility upcoming at Tarapur & Vapi,
per US-FDA Standard.
- In
house R & D Center, with Ultra modern ,
sophisticate Instruments, equipped with a Team
of Highly skilled scientists, working round
the clock on New Products and Process Improvements.
- Expected
to receive CoS for Ramipril, Budesonide, Venlafaxine,
in year 2004, for marketing products in Western
Europe.
- E-DMFs
in CTD Formats available for most of the commercialized
molecules.
- All
products match specifications of BP / USP /
EP, as applicable.
-
Esteemed clients in Domestic Market, serviced
by us are, Ranbaxy, Sun Pharma, Cipla, Aristo
, Astra- Zeneca Pharma India, Maral Labs., Cadila
Healthcare, German Remedies, Intas, Biotrans,
Dr. Reddys Laboratory (DRL)
- Per
individual client’s need , can also provide
“Tailor Made Products” for physical
parameters viz: Particle size ( micronised material),
Bulk Density etc., as well Impurity profile,
Methods for Testing etc.
- We
also offer Intermediates of most of our APIs
( Pl. refer to Product List).
- Products
under Patent will NOT be sold until Patent expiration
in Buyer’s Country. Purchase of Patented
Product will be sole responsibility of the Buyer.
-
Bulk
Pharmaceuticals
- Bulk
Drugs Under R&D
|
|
|
